找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hematologic Challenges in the Critically Ill; Aryeh Shander,Howard L. Corwin Book 2018 Springer International Publishing AG, part of Sprin

[復(fù)制鏈接]
樓主: 母牛膽小鬼
41#
發(fā)表于 2025-3-28 17:50:38 | 只看該作者
42#
發(fā)表于 2025-3-28 21:33:24 | 只看該作者
43#
發(fā)表于 2025-3-29 02:02:46 | 只看該作者
Hematologic Challenges in ICU Patients with Malignancy,den. Oncogenes activate blood coagulation as an integral feature of neoplastic transformation whereby cancer cells support clot formation and clotting proteins support cancer growth and dissemination. A complex coagulopathy develops characterized by activation of clotting mechanisms to different ext
44#
發(fā)表于 2025-3-29 03:06:22 | 只看該作者
45#
發(fā)表于 2025-3-29 08:01:06 | 只看該作者
46#
發(fā)表于 2025-3-29 13:37:17 | 只看該作者
Current Risks of Transfusion,al risks. Over time, the risks associated with transfusion have become increasingly well understood. However, most clinicians think only of transfusion-transmitted infections such as hepatitis B and C and human immunodeficiency virus in regard to transfusion risk. There are many other transfusion ri
47#
發(fā)表于 2025-3-29 17:19:09 | 只看該作者
Clinical Outcomes and Red Blood Cell Storage, blood cell transfusions (Shehata et al. Transfusion 54:2631-9, 2014; Vincent, JAMA 288:1499-507, 2002; Corwin, Crit Care Med 32:39-52, 2004). Our understanding of the biochemical, structural, and functional changes that occurs to red blood cells with storage – also known as the storage lesion – has
48#
發(fā)表于 2025-3-29 19:43:11 | 只看該作者
49#
發(fā)表于 2025-3-30 01:12:39 | 只看該作者
Therapeutic Apheresis for Hematologic Emergencies,s, most often discarding one (red cells, plasma, white cells, or platelets); and returned to the patient with or without extracorporeal modification or a replacement fluid. Multiple TA modalities can be used in the intensive care setting including therapeutic plasma exchange, red blood cell exchange
50#
發(fā)表于 2025-3-30 06:57:30 | 只看該作者
Intravenous Oxygen Therapeutics: A Revolution in Medicine Yet to Be Realized?,has pursued an oxygen therapeutic since the early 1930s with actually some spotty points of success. There are places in the world today that such agents are available, but they have not realized their potential. Two distinctly different pharmaceutical approaches are under accelerated development: h
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 02:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
黄陵县| 安岳县| 辉县市| 定安县| 宜兰县| 宁海县| 甘泉县| 灵山县| 卢湾区| 年辖:市辖区| 武隆县| 屯昌县| 容城县| 木兰县| 固始县| 晋中市| 会泽县| 陕西省| 莱阳市| 包头市| 南岸区| 黄骅市| 普定县| 额尔古纳市| 方城县| 嘉义县| 贵南县| 株洲县| 藁城市| 奉节县| 仲巴县| 东宁县| 临西县| 县级市| 新竹市| 泗水县| 靖州| 镇赉县| 崇阳县| 比如县| 怀仁县|